News
A combination of lisocabtagene maraleucel (liso-cel, Breyanzi) plus ibrutinib (Imbruvica) demonstrated a trend for better ...
Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...
Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.
As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company ...
Lilly has already onboarded 100 professionals at the Hyderabad facility and plans to expand the headcount to 1,500 over the ...
Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...
Telangana Chief Minister A Revanth Reddy inaugurated Eli Lilly’s new technology hub in Hyderabad, marking a significant leap ...
Eli Lilly and Company faces unexpected stock plunge despite strong growth, prompting caution and reflection among investors in the pharmaceutical sector.
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...
4h
Zacks Investment Research on MSNShould You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?
Eli Lilly and Company LLY will report its second-quarter earnings on Aug. 7, before market open. The Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results